[go: up one dir, main page]

WO1997009971A3 - Reservoirs a medicament superabsorbant et de grande capacite a utiliser dans des systemes d'administration transdermique de medicaments - Google Patents

Reservoirs a medicament superabsorbant et de grande capacite a utiliser dans des systemes d'administration transdermique de medicaments Download PDF

Info

Publication number
WO1997009971A3
WO1997009971A3 PCT/US1996/014784 US9614784W WO9709971A3 WO 1997009971 A3 WO1997009971 A3 WO 1997009971A3 US 9614784 W US9614784 W US 9614784W WO 9709971 A3 WO9709971 A3 WO 9709971A3
Authority
WO
WIPO (PCT)
Prior art keywords
reservoirs
drug
high capacity
delivery systems
superabsorbent
Prior art date
Application number
PCT/US1996/014784
Other languages
English (en)
Other versions
WO1997009971A2 (fr
Inventor
Tung-Fen Chen
Chia-Ming Chiang
Janan Jona
Priti Joshi
Asha Ramdas
Original Assignee
Tung-Fen Chen
Chia-Ming Chiang
Janan Jona
Priti Joshi
Asha Ramdas
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tung-Fen Chen, Chia-Ming Chiang, Janan Jona, Priti Joshi, Asha Ramdas, Cygnus Therapeutic Systems filed Critical Tung-Fen Chen
Priority to AU72388/96A priority Critical patent/AU7238896A/en
Publication of WO1997009971A2 publication Critical patent/WO1997009971A2/fr
Publication of WO1997009971A3 publication Critical patent/WO1997009971A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention porte sur des réservoirs à médicament de grande capacité destinés à être incorporés à des dispositifs d'administration transdermique de médicament. Ces réservoirs sont constitués de matériau superabsorbant, généralement un polymère réticulé, capable d'absorber une quantité de formulation pharmaceutique correspondant à au moins 15 grammes de formulation par gramme de matériau. L'invention porte également sur des procédés de fabrication de dispositifs transdermiques contenant ces réservoirs ainsi que sur leur utilisation.
PCT/US1996/014784 1995-09-14 1996-09-13 Reservoirs a medicament superabsorbant et de grande capacite a utiliser dans des systemes d'administration transdermique de medicaments WO1997009971A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU72388/96A AU7238896A (en) 1995-09-14 1996-09-13 High capacity, superabsorbent drug reservoirs for use in transdermal drug delivery systems

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US52865595A 1995-09-14 1995-09-14
US08/528,655 1995-09-14
US58284395A 1995-12-29 1995-12-29
US08/582,843 1995-12-29
US08/713,071 1996-09-12

Publications (2)

Publication Number Publication Date
WO1997009971A2 WO1997009971A2 (fr) 1997-03-20
WO1997009971A3 true WO1997009971A3 (fr) 1997-04-24

Family

ID=27062784

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/014784 WO1997009971A2 (fr) 1995-09-14 1996-09-13 Reservoirs a medicament superabsorbant et de grande capacite a utiliser dans des systemes d'administration transdermique de medicaments

Country Status (2)

Country Link
AU (1) AU7238896A (fr)
WO (1) WO1997009971A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7309497B2 (en) 2000-08-24 2007-12-18 Schwarz Pharma Ag Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients
US7632859B2 (en) 2002-12-02 2009-12-15 Schwarz Pharma Ag Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
US9186335B2 (en) 2002-07-30 2015-11-17 Ucb Pharma Gmbh Hot melt TTS for administering rotigotine

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5902603A (en) * 1995-09-14 1999-05-11 Cygnus, Inc. Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
WO1997024148A1 (fr) * 1995-12-29 1997-07-10 Cygnus, Inc. Systemes et procedes d'administration percutanee d'agents androgenes
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE10128685A1 (de) * 2001-06-13 2002-12-19 Beiersdorf Ag Selbstklebendes, wirkstoffhaltiges Matrixpflaster auf Basis von Polyurethangelen
DE10220114A1 (de) * 2002-05-06 2003-11-20 Beiersdorf Ag Ätherische Öle enthaltendes Matrixpflaster auf Polyurethanbasis
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297769A1 (fr) * 1987-06-29 1989-01-04 E.R. Squibb & Sons, Inc. Procédé de fabrication d'un pansement comprenant une couche adhésive acrylique hydrophile.
EP0399432A2 (fr) * 1989-05-25 1990-11-28 Takeda Chemical Industries, Ltd. Composition thérapeutique transdermique
EP0405993A2 (fr) * 1989-06-28 1991-01-02 James River Corporation Of Virginia Pansemet superabsorbant
US5248676A (en) * 1990-05-17 1993-09-28 Hisamitsu Pharmaceutical Co., Inc. Estradiol percutaneous administration preparations
US5328935A (en) * 1993-03-26 1994-07-12 The Procter & Gamble Company Method of makig a superabsorbent polymer foam

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297769A1 (fr) * 1987-06-29 1989-01-04 E.R. Squibb & Sons, Inc. Procédé de fabrication d'un pansement comprenant une couche adhésive acrylique hydrophile.
EP0399432A2 (fr) * 1989-05-25 1990-11-28 Takeda Chemical Industries, Ltd. Composition thérapeutique transdermique
EP0405993A2 (fr) * 1989-06-28 1991-01-02 James River Corporation Of Virginia Pansemet superabsorbant
US5248676A (en) * 1990-05-17 1993-09-28 Hisamitsu Pharmaceutical Co., Inc. Estradiol percutaneous administration preparations
US5328935A (en) * 1993-03-26 1994-07-12 The Procter & Gamble Company Method of makig a superabsorbent polymer foam

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7309497B2 (en) 2000-08-24 2007-12-18 Schwarz Pharma Ag Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients
US9186335B2 (en) 2002-07-30 2015-11-17 Ucb Pharma Gmbh Hot melt TTS for administering rotigotine
US7632859B2 (en) 2002-12-02 2009-12-15 Schwarz Pharma Ag Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease

Also Published As

Publication number Publication date
WO1997009971A2 (fr) 1997-03-20
AU7238896A (en) 1997-04-01

Similar Documents

Publication Publication Date Title
WO1999033853A3 (fr) Hydrates de carbone derives, utiles dans des systemes de liberation solides
CA2286001A1 (fr) Composition pour implants a base de particules de verre
AU628647B2 (en) Osmotically enhanced absorbent structures
WO1997009971A3 (fr) Reservoirs a medicament superabsorbant et de grande capacite a utiliser dans des systemes d'administration transdermique de medicaments
AU3884589A (en) Intravenous pharmaceutical composition comprising cyclosporins
CA2004598A1 (fr) Aerosols medicinaux
CA2313642A1 (fr) Formulations pharmaceutiques a base d'hydrogel, dispositifs d'administration de medicaments et procedes
CA2150119A1 (fr) Substances pharmaceutiques au gout masque
AU5076990A (en) Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
NZ336462A (en) Pharmaceutical composition of fenofibrate with high biological availability
EP1516615A3 (fr) Systèmes d'administration de substances solides, pour la libération controlée de molécules incorporées dans ces substances et procédés de fabrication de ces systèmes
EP0346707A3 (en) Dental materials
WO1998027963A3 (fr) Procedes et composition a base de gel
EP0392426A3 (fr) Lotion pour le corps et les mains sans émulsifiant
PL289322A1 (en) Method of obtaining a composition of controllable release of medicine contained therein
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
CA2187353A1 (fr) Compositions liquides a diffusion
AU4101693A (en) Subcutaneous implantable multiple agent delivery system
EP0528035A4 (en) Polyelectrolyte complex antibacterial agent and antibacterial material
ZA899780B (en) Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least one active product
IE880533L (en) Pharmaceutical delivery device
CA2225162A1 (fr) Tubulure medical orientee
CA2265678A1 (fr) Recipients pour administration de medicaments par electrotransport, contenant des charges inertes
AU6708994A (en) Foam cell drug delivery
CA2231648A1 (fr) Reservoirs a medicament a base d'hydrogel de polyurethane a utiliser dans des systemes d'administration transdermique de medicaments

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA